Diseases affecting the brain and central nervous system represent one of the largest global healthcare challenges and greatest medical needs due to the devastating personal and economic consequences for patients, caregivers and society.

Despite the fact that an estimated 55 million people worldwide suffer from neurodegenerative diseases, and this incidence is expected to double every 20 years, there are currently no approved disease-modifying therapies or cures available. Leveraging its three integrated platforms, Yumanity Therapeutics’ innovative new approach to drug discovery and development concentrates on reversing the cellular phenotypes and disease pathologies caused by protein misfolding.

LEARN MORE

LATEST NEWS

August 8, 2016

Susan Lindquist Receives Albany Medical Center Prize in Medicine and Biomedical Research

VIEW MORE

American and German Researchers to Share $500K Medical Prize

VIEW MORE

Researchers Hartl, Horwich and Lindquist Win Nation’s Largest Prize for Science and Medicine

VIEW MORE

ARCHIVE